Company / FCF Margin
AYTU BIOPHARMA, INC FCF Margin History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-3.3%
FY2025
5-year range
-43.1% / -2.6%
FY2021-FY2025
Trend
-24.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin has fluctuated over the past 9 years, ranging from -2534.3% in FY2015 to -2.6% in FY2024.
Based on SEC 10-K filings.
-3.3% in FY2025 with a 10-year CAGR of +2531.0%.
Improved from -29.8% to -3.3% over the past 3 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +26.6pp
- 5-Year Change
- +99.4pp
- 10-Year Change
- +2531.0pp
Key checks
Key Insights
- In FY2025, fcf margin decreased 24.0% year-over-year.
- Peak fcf margin was recorded in FY2024.
- Lowest fcf margin in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -3.3% | -24.0% |
| FY2024 | -2.6% | - |
| FY2023 | - | - |
| FY2022 | -29.8% | +30.9% |
| FY2021 | -43.1% | +58.0% |
| FY2020 | -102.7% | +76.5% |
| FY2018 | -437.5% | -1.1% |
| FY2017 | -432.7% | -1.6% |
| FY2016 | -425.8% | +83.2% |
| FY2015 | -2534.3% | +62.0% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026